ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,120,986 | +826.8% | 396,339 | +798.7% | 0.02% | +1000.0% |
| Q2 2023 | $876,267 | -65.0% | 44,100 | -69.9% | 0.00% | -71.4% |
| Q1 2023 | $2,505,759 | +78.0% | 146,279 | +103.3% | 0.01% | +75.0% |
| Q4 2022 | $1,408,062 | -74.0% | 71,950 | -78.8% | 0.00% | -77.8% |
| Q3 2022 | $5,410,000 | +79.6% | 338,999 | +54.8% | 0.02% | +80.0% |
| Q2 2022 | $3,013,000 | -22.3% | 218,962 | -10.5% | 0.01% | -9.1% |
| Q1 2022 | $3,880,000 | -28.4% | 244,650 | -1.4% | 0.01% | -8.3% |
| Q4 2021 | $5,416,000 | -12.8% | 248,114 | +19.4% | 0.01% | -14.3% |
| Q3 2021 | $6,213,000 | -16.8% | 207,875 | +23.3% | 0.01% | -17.6% |
| Q2 2021 | $7,466,000 | -49.2% | 168,569 | -49.1% | 0.02% | -55.3% |
| Q1 2021 | $14,699,000 | +159.0% | 331,286 | +220.1% | 0.04% | +137.5% |
| Q4 2020 | $5,675,000 | +1609.3% | 103,480 | +613.3% | 0.02% | +1500.0% |
| Q3 2020 | $332,000 | -31.0% | 14,507 | -36.9% | 0.00% | -50.0% |
| Q2 2020 | $481,000 | – | 22,986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |